FINRA Launches New Data On Treasuries Trading

FINRA for the first time posted weekly, aggregate data on the trading volume of Treasury securities reported to TRACE®, FINRA’s Trade Reporting and Compliance Engine®.

The new Treasury Aggregate Statistics report provides trading volume in U.S. Treasury securities reported to TRACE for the prior week. The information is aggregated by Treasury security subtype: bills, floating rate notes (FRN), nominal coupons, and Treasury inflation-protected securities (TIPS). The data are further grouped into two categories: alternative trading system/interdealer transactions, and dealer-to-customer transactions.

For nominal coupons and TIPS, the report also shows remaining maturity and on-the-run/off-the run buckets.

Securities firms began reporting Treasury transactions to FINRA in July 2017, with the goal of providing regulators and policymakers with additional information to increase understanding and enhance surveillance of this bellwether market.

”Publishing this important data will increase transparency for the benefit of investors and other market participants,” said Thomas Gira, Executive Vice President, Market Regulation and Transparency Services. “We look forward to continue working with the Treasury Department, the SEC and the Federal Reserve Board to advance market transparency and sound oversight and policymaking.”

Source: FINRA

Related articles

  1. Aberdeen AM Looks to Grow In China

    The trading platform has onboarded 2012 investors from 33 jurisdictions.

  2. Europe Leads Sustainable Investing

    The exchange has launched a new ESG index and its first ESG future.

  3. Canadian Bonds Move Toward E-Trading

    Bond Evaluated Price uses all bond transactions across the group with a proprietary model.

  4. From The Markets

    Neptune Closes Capital Raise

    Client coverage will expand in the U.S. where the fixed income network has grown in the past 18 months.

  5. The update of the Social Bond Principles accompanies a surge of issuance addressing COVID-19.